SEC Form 4/A · accession 0001209191-16-122888
NEUROCRINE BIOSCIENCES INC · NBIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
W Thomas Mitchell
Director
Period of report
May 28, 2015
Accepted (ET)
May 24, 2016 · 3:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000914475
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $42.76 | May 28, 2015 | A | 25,000 | A | Jun 28, 2015 | May 27, 2025 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1Option vests in 12 equal monthly installments beginning June 28,2015.
Remarks
Form 4(A) is being filed to attach the Power of Attorney which was inadvertently omitted at the original filing of the Form 4.